Old Web
English
Sign In
Acemap
>
Paper
>
Defining optimal combinations of PI3K/Akt/mTOR and Ras/Raf/MAPK pathway inhibitors for use in endometrial cancer
Defining optimal combinations of PI3K/Akt/mTOR and Ras/Raf/MAPK pathway inhibitors for use in endometrial cancer
2014
Sara Isani
Alicia Rodriguez-Gabin
Gary L. Goldberg
Susan Band Horwitz
Hayley M. McDaid
Keywords:
Protein kinase B
MAPK/ERK pathway
PI3K/AKT/mTOR pathway
RPTOR
Cancer research
Endometrial cancer
General surgery
Medicine
Anti-apoptotic Ras signalling cascade
Gynecology
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]